Article ID Journal Published Year Pages File Type
320112 European Neuropsychopharmacology 2015 11 Pages PDF
Abstract

•Metoclopramide, a dopamine D2-receptor antagonist, modified the perception of time in healthy subjects׳ decision making.•Participants taking the drug were more willing to wait in order to gain a higher probability of obtaining a reward.•Medicated subjects showed less activity during the task in the postcentral gyrus as well as frontomedian áreas.•A regressor of subjective value led to activation in the VMOFC, in line with the existing literature.

Studies on animals and humans have demonstrated the importance of dopamine in modulating decision-making processes. In this work, we have tested dopaminergic modulation of economic decision-making and its neural correlates by administering either placebo or metoclopramide, a dopamine D2-receptor antagonist, to healthy subjects, during a functional MRI study. The decision-making task combined probability and time delay with a fixed monetary reward. For individual behavioral characterization, we used the Probability Time Trade-off (PTT) economic model, which integrates the traditional trade-offs of reward magnitude-time and reward magnitude-probability into a single measurement, thereby quantifying the subjective value of a delayed and probabilistic outcome. A regression analysis between BOLD signal and the PTT model index permitted to identify the neural substrate encoding the subjective reward-value. Behaviorally, medication reduced the rate of temporal discounting over probability, reflected in medicated subjects being more prone to postpone the reward in order to increase the outcome probability. In addition, medicated subjects showed less activity during the task in the postcentral gyrus as well as frontomedian areas, whereas there were no differences in the ventromedial orbitofrontal cortex (VMOFC) between groups when coding the subjective value. The present study demonstrates by means of behavior and imaging that dopamine modulation alters the probability-time trade-off in human economic decision-making.

Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, , , , , , , ,